Effects and Safety of a Novel Oral Potassium-Lowering Drug-Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia: a Systematic Review and Meta-Analysis

BACKGROUND: Oral sodium zirconium cyclosilicate (SZC) is a novel potassium binder capable of achieving a rapid reduction of serum potassium (sK(+)) and maintaining a long-term normokalemia. We undertook a meta-analysis to summarize and evaluate the effects surrounding SZC in patients with hyperkalem...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yaru, Xu, Ruiling, Wang, Fanghao, Liu, Youxia, Xu, Junying, Zhao, Na, Cheng, Fajuan, Long, Lihong, Jia, Junya, Lin, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452568/
https://www.ncbi.nlm.nih.gov/pubmed/33459923
http://dx.doi.org/10.1007/s10557-020-07134-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452568/
https://www.ncbi.nlm.nih.gov/pubmed/33459923
http://dx.doi.org/10.1007/s10557-020-07134-2

Ejemplares similares